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The TNF and TNF Receptor Review
Superfamilies: Integrating
Mammalian Biology
The receptors and ligands in this superfamily have
unique structural attributes that couple them directly to
signaling pathways for cell proliferation, survival, and
differentiation. Thus, they have assumed prominent
roles in the generation of tissues and transient microen-
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cesses as seemingly disparate as host defense and or-
ganogenesis. In interpreting this large and highly active
area of research, we have focused on common themesIntroduction
that unite the actions of these genes in different tissues.
We also discuss the evolutionary success of this super-Three decades ago, lymphotoxin (LT) and tumor necro-
sis factor (TNF) were identified as products of lympho- family—success that we infer from its expansion across
the mammalian genome and from its many indispens-cytes and macrophages that caused the lysis of certain
types of cells, especially tumor cells (Granger et al., able roles in mammalian biology.
1969; Carswell et al., 1975). When the cDNAs encoding
LTa and TNF were cloned (Gray et al., 1984; Pennica et Structure/Function Relationships of TNFRs
al., 1984), they were similar to one another and, eventu- The normal functions of TNF/TNFR SFPs, as well as
ally, it became clear that they were members of a gene certain diseases involving them, depend on the obliga-
superfamily. Not surprisingly, the receptors for these tory 3-fold symmetry that defines the essential signaling
proteins also constitute a TNF receptor (TNFR)-related stoichiometry and structure (Figure 1). The ligands are
gene superfamily. Large-scale sequencing of “ex- type 2 proteins that can have both membrane-embed-
pressed sequence tags” (ESTs) identified many related ded “pro” as well as cleaved, soluble “mature” forms
proteins, collectively referred to here as TNF- and TNFR- (for review, see Idriss and Naismith, 2000). Both forms
related superfamily proteins (TNF/TNFR SFPs; reviewed are active as self-assembling noncovalent trimers,
in Smith et al., 1994; Ashkenazi and Dixit, 1998; Wallach whose individual chains fold as compact “jellyroll” b sand-
et al., 1999; Idriss and Naismith, 2000; http://www.gene. wiches and interact at hydrophobic interfaces (Fesik,
UCL.ac.uk/users/hester/tnfinfo.html). The familiar as 2000) (Figure 1A). The 25%–30% amino acid similarity
well as standardized names of these proteins are listed between TNF-like ligands is largely confined to internal
in Table 1, together with their gene locations, pheno- aromatic residues responsible for trimer assembly. The
types caused by mutations in these genes, and identified external surfaces of ligand trimers show little sequence
functions. similarity, which accounts for receptor selectivity (Figure
The discovery that cachectin, a protein known to 2). The ligand shape is that of an inverted bell that is
cause fever and wasting, was identical to TNF provided embraced on three sides at the base by elongated re-
an early illustration of the importance of members of ceptor chains forming a 3:3 symmetric complex (Figures
this family in human disease (Beutler and Cerami, 1986). 1A–1C). Certain ligands and receptors in the TNF/TNFR
Though systemic toxicity dashed early hopes of using SFP can bind more than one partner with specific high
LTa and TNF as anti-tumor agents, the discovery of new affinity (Kd 5 1029–10210 M), thereby enhancing regula-
TNF/TNFR SFPs unveiled new lines of investigation into tory flexibility and complexity (Idriss and Naismith,
host defense, inflammation, apoptosis, autoimmunity, 2000). After ligand binding, the receptor cytoplasmic
and organogenesis. The potent biological effects of tails form a 3:3 internal complex with signaling proteins
TNF/TNFR SFPs participate in human diseases and may such as TRAF2 or FADD (McWhirter et al., 1999) (Figure
be harnessed to ameliorate certain illnesses (Siegel et 1F). Hence, ligand binding and signal complex formation
al., 2000). Pharmaceuticals to inhibit TNF have been involve stoichiometrically defined protein complexes
developed which control previously recalcitrant inflam- with 3-fold symmetry. How evolution settled on tri-fold
matory conditions such as rheumatoid arthritis and in- symmetry is unclear. Trimers require more contacts than
flammatory bowel disease (Maini and Taylor, 2000; Pa- dimers and may cause an exponential increase in avid-
padakis and Targan, 2000). Indeed, for reasons we ity. Trimers could also be necessary to project elongated
outline below, TNF and other TNF/TNFR SFPs are now receptor chains upright on the cell surface. Though few
being targeted for therapies against widespread human other things in nature occur in threes, trimers provide a
diseases such as atherosclerosis, osteoporosis, auto- unity of design and function for these receptor/ligand
immune disorders, allograft rejection, and cancer. superfamilies.
TNFR-like receptors are type 1 transmembrane pro-
teins that adopt elongated structures by a scaffold ofk E-mail: locksley@medicine.ucsf.edu (R. M. L.), nigel@itsa.ucsf.edu
(N. K.), lenardo@nih.gov (M. J. L.) disulfide bridges (Figures 1D and 1E). The disulfide
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Table 1. Members of the TNF/TNFR Superfamily
Human Mouse Phenotypes associated Additional functional
Standardized Other Names Accession Chromosome Chromosome with mutations observations
Receptor
NGFR TNFRSF16 p75 M14764 17q21-q22 11, 55.6 cM Defective sensory neuron in-
nervation; impaired heat
sensitivity
Troy TNFRSF19 Taj AF167555 13q12.11-12.3 14 Expressed in hair follicles and
epithelium; the mouse gene
is located near the waved
coat locus.
EDAR AF130988 2q11-q13 10, 29.0 cM Hypohydrotic ectodermal dys-
plasia — abnormal tooth, hair
and sweat gland formation
XEDAR EDA-A2R AF298812 X Likely role in skin, hair and
tooth formation
CD40 TNFRSF5 p50, Bp50 X60592 20q12-q13.2 2, 97.0 cM Defective Ig class switching
and GC formation causing
immunodeficiency
DcR3 TNFRSF6B AF104419 20q13 Secreted decoy receptor for
FasL with possible role in
tumor evasion
FAS TNFRSF6 CD95, APO-1, APT1 M67454 10q24.1 19, 23.0 cM Impaired activation-induced T
cell death; lymphoprolifera-
tion; autoimmunity (ALPS)
OX40 TNFRSF4 CD134, ACT35, TXGP1L X75962 1p36 4, 79.4 cM Defective T cell responses
AITR TNFRSF18 GITR AF125304 1p36.3 4 Glucocorticoid-induced;
inhibits T cell receptor-
dependent apoptosis
CD30 TNFRSF8 Ki-1, D1S166E M83554 1p36 4, 75.5 cM Marker of Reed-Sternberg cells
in Hodgkin’s disease
HveA TNFRSF14 HVEM, ATAR, TR2, LIGHTR U70321 1p36.3-p36.2 Probable role in T cell prolifera-
tion and receptor for herpes
simplex virus
4-1BB TNFRSF9 CD137, ILA L12964 1p36 4, 75.5 cM Probable role in T cell
responses
TNFR2 TNFRSF1B CD120b, p75, TNFBR, M32315 1p36.3-p36.2 4, 75.5 cM Increased sensitivity to bacte-
TNFR80, TNF-R-II rial pathogens; decreased
sensitivity to LPS; reduced
antigen-induced T cell
apoptosis
DR3 TNFRSF12 TRAMP, WSL-1, LARD, U72763 1p36.2 A linked, partially duplicated
WSL-LR, DDR3, TR3, copy of the gene encodes a
APO-3 potential decoy receptor
CD27 TNFRSF7 Tp55, S152 M63928 12p13 6, 60.35 cM Defective T cell responses
TNFR1 TNFRSF1A CD120a p55-R, TNFAR M75866 12p13.2 6, 60.55 cM Impaired clearance of bacterial
TNFR60 TNF-R-I pathogens; resistance to
LPS; LN present; defective
GC formation; defective PP
formation
LTbR TNFRSF3 TNFR2-RP, TNFCR, L04270 12p13 6, 60.4 cM Absence of LN, PP; defective
TNF-R-III GC formation
RANK TNFRSF11A TRANCE-R AF018253 18q22.1 Osteopetrosis; absence of os- Required for lactating mam-
teoclasts; absence of lymph mary gland development
nodes; PP present; abnor-
mal B cell development
TACI CAML AF023614 17p11 11 Probable role in B cell re-
interactor sponses
BCMA TNFRSF17 BCM Z29574 16p13.1 Probable role in B cell re-
sponses





Human Mouse Phenotypes associated Additional functional
Standardized Other Names Accession Chromosome Chromosome with mutations observations
Receptor
OCIF, TR1 Osteoporosis; arterial calcifi-
OPG TNFRSF11B osteoprotegerin U94332 8Q24 cation
Probable inducer of lymphocyte
DR4 TNFRSF10A Apo2, TRAILR-1 U90875 8p21 death and activation
KILLER, TRICK2A, Probable inducer of lymphocyte
DR5 TNFRSF10B TRAIL-R2, TRICKB AF012628 8p22-p21 death and activation
GPI-linked decoy receptor—
interferes with TRAIL
DcR1 TNFRSF10C TRAILR3, LIT, TRID AF012536 8p22-p21 signaling
Transmembrane decoy recep-
tor—interferes with TRAIL
DcR2 TNFRSF10D TRUNDD TRAILR4 AF029761 8p21 signaling
Ligand
EDA EDA1 NM_001399 Xq12-q13.1 X, 37.0 cM Hypohydrotic ectodermal
dysplasia – abnormal tooth,
hair and sweat gland
formation
CD40L TNFSF5 IMD3, HIGM1, TRAP, X67878 Xq26 X, 18.0 cM Defective T cell and IgG re-
CD154, gp39 sponses; hyper IgM syn-
drome
FasL TNFSF6 APT1LG1 U11821 1q23 1, 85.0 cM Impaired activation-induced
T cell death; lymphoprolifera-
tion; autoimmunity; ALPS
OX40L TNFSF4 gp34 TXGP1 D90224 1q25 1, 84.9 cM Defective T cell responses
AITRL TNFSF18 TL6, hGITRL AF125303 1q23 Inhibits T cell receptor-depen-
dent apoptosis
CD30L TNFSF8 L09753 9q33 4, 32.2 cM Possible role in malignant lym-
phocyte disorders
VEGI TNFSF15 TL1 AF039390 Potential vascular endothelial
cell growth inhibitor
LIGHT TNFSF14 LT_, HVEM-L AF036581 19 (probable) 17
4-1BBL TNFSF9 U03398 19p13.3 17 Defective T cell responses
CD27L TNFSF7 CD70 L08096 19p13 17, 20.0 cM
LTa TNFSF1 TNFB, LT X01393 6p21.3 17, 19.06 cM Absence of LN and PP; disorga-
nized splenic microarchitec-
ture; defective GC formation
TNF TNFSF2 tumor necrosis factor; X01394 6p21.3 17, 19.06 LN present; defective GC forma-
cachectin, TNFA, DIF tion; increased susceptibility
to microbial pathogens
LTb TNFSF3 TNFC, p33 L11015 6p21.3 17, 19.061 Absence of peripheral LN and
PP; presence of mesenteric
and some cervical LN; defec-
tive GC formation
TWEAK TNFSF12 DR3L APO3L AF030099 17p13 11? Potential role in monocyte and
NK cell cytotoxicity
APRIL TNFSF13 NM_003808 17p13.1 11? Probable role in B cell re-
sponses
BLYS TNFSF13B BAFF, THANK, TALL1 AF132600 13q32-34 Probable role in B cell re-
sponses
RANKL TNFSF11 TRANCE, OPGL, ODF AF013171 13q14 14, 45.0 Osteopetrosis; absence of os- Required for lactating mammary
teoclasts; absence of lymph gland development
nodes; PP present; normal
splenic architecture; abnor-
mal B cell and T cell devel-
opment
TRAIL TNFSF10 Apo-2L TL2 U37518 3q26
Cell
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Figure 1. Structure of TNF/TNFR Interaction
(A) Trimeric structure of TNF. Structure of the TNF trimer shown from the top (upper) and side (lower) views with each monomer differently
colored. The b-pleated sheets assume a “jellyroll” orientation in each monomer (adapted from Eck and Sprang, 1989).
(B) Trimeric symmetry of the structure of the active domain of TNFR1 complexed with LTa. The elongated ladder of disulfide bridges for the
receptor chains (light green, blue, and crimson) is highlighted in red. The predominant contacts occur between the trimeric ligand (chains in
dark green and brown) and the middle of the ectodomain in the region of CRD2 (Banner et al., 1993).
(C) LTa/TNFR1 structure from a “top” view looking down at the membrane revealing the tri-fold symmetry in which the receptor chains
embrace the ligand at each vertex of a triangle formed by the apposition of ligand monomers.
(D) Neutral pH structure of the unliganded TNFR1 ectodomain. A parallel dimer with extensive contacts in the PLAD region comprising CRD1
is shown. An anti-parallel dimer, not shown, was also observed (Naismith et al., 1995).
(E) Structure of the liganded monomeric complex. Contact structure modeled on the interaction between a monomer of LTa and a monomer
of TNFR1 showing that the ligand contacts are made primarily in CRD2 but not CRD1 (Banner et al., 1993).
(F) The trimeric structure of TRAF complexes with CD40 peptides. The three TRAF monomers (light blue, dark blue, and green) extensively
contact each other and interact at the tips of the globular N-terminal domains with the cytoplasmic portions of receptor monomers as illustrated
by the position of receptor peptides (yellow or gold) indicated by the arrows (McWhirter et al., 1999).
bonds form “cysteine-rich domains” (CRDs) that are the al., 1993). From this it was inferred that the ligand re-
cruited or “cross-linked” three receptor monomers intohallmark of the TNFR superfamily (e.g., see alignments
of amino-terminal CRDs in Figure 3). These 40 amino the final 3:3 complex. This view has been recently chal-
lenged by findings that several receptors in the TNFRacid pseudorepeats are typically defined by 3 intrachain
disulfides generated by 6 highly conserved cysteines family self-assemble in the absence of ligand and signal-
ing involves rearrangement of the preassembled chains(Smith et al., 1994). The elongated receptor chains fit
in the “grooves” between protomers within the ligand (Chan et al., 2000a; Siegel et al., 2000). The structure
of TRAIL complexed with its receptor DR5 reveals atrimer. For Fas and TNFR1, ligand contacts occur mainly
in the 2nd and 3rd CRDs (counted from the N terminus). remarkable conservation of the same 3-fold ligand-
receptor complex as seen for LTa/TNFR1 despite a mini-The crystal structure of LTa in complex with the TNFR1
extracellular domain reveals no contact between indi- mum of primary sequence similarity (Hymowitz et al.,
1999).vidual receptor chains (Figures 1C and 1D) (Banner et
Review
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Figure 2. Sequence Alignment of the TNF-Related Proteins
Residues are shaded (yellow for identities, red for conservative substitutions) where they occur in 30% of the grouped sequences. Green
shading highlights the corresponding locations of intron excision sites from the mRNAs that encode the proteins. The locations of b strands
in the LTa structure are shown at the top of the alignment. Alignments were generated using CLUSTALW.
TNFRs can display noncanonical functions that do adaptor that promotes homotypic association (Figure 4).
By contrast, the TRAF binding motif is a stretch of aminonot require binding trimer ligands. For example, NGFR
binds neurotropins, ligands with no structural resem- acids (less than a dozen contact residues) in the receptor
tail that is clutched by a pocket in the globular headblance to TNF, and interacts with the Trk family of tyro-
sine kinase receptors that are unrelated to TNFRs. Thus, group of the adaptor through charged residues (Figure
1F). Signaling is extremely rapid and highly specific.the NGFR gene, with a dissimilar distribution of introns,
may have been formed early in the evolution of the TNFR For the subset of receptors that have DDs, often called
“death receptors” (DR), ligand engagement typicallySF. HveA, formerly HVEM, another TNFR SFP, is a recep-
tor for Herpesvirus, type 1, and binds the TNF-like ligand, causes the association of adaptors such as Fas-associ-
ated DD protein (FADD) and TNFR-associated DD pro-LIGHT (Mauri et al., 1998). Similarly, the avian TNFR-
like TVB(S1), TVB(S3)(CAR-1), and TVB(T) molecules are tein (TRADD) that ultimately cause caspase activation
and cell death. For Fas, the homotypic association ofreceptors for avian leukosis viruses (Adkins et al., 2000).
Whether these functions require preassembly and re- FADD with the Fas DD leads to the recruitment of cas-
pase-8 or -10 by homotypic interactions between “deathceptor trimers are subjects of ongoing research.
effector domains” (DEDs) contained in FADD and the
prodomain of these two caspases (Scaffidi et al., 1999).Two Pivotal Modes of Signaling
The cytoplasmic domains of TNFRs are modest in length Why adaptors? An obvious answer is that modularity
allows regulatory flexibility. The DD, DED, and “caspase-and function as docking sites for signaling molecules.
Signaling occurs through two principal classes of cyto- recruitment domain” (CARD), despite only 10%–20%
sequence identity, all share the same overall 6 a-helicalplasmic adaptor proteins: TRAFs (TNF receptor–associ-
ated factors) and “death domain” (DD) molecules (re- structure (Fesik, 2000). This suggests a common origin
from a prototype molecule that became specialized forviewed in Fesik, 2000; Inoue et al., 2000). In mammals,
at least six TRAF molecules and a number of nonrecep- roles at different points in the signaling pathway. For
example, whereas DD and DED play essential associa-tor DD molecules have evolved at locations spread
through the genome (Wajant et al., 1999). The signaling tive roles in death receptor pathways, the CARD has
been diversified for mitochondrial death pathways andadaptor is selected by whether the cytoplasmic domain
of the receptor harbors either a DD or a TRAF binding inflammatory responses (Fesik, 2000; Humke et al.,
2000). The DD also resembles the “ankyrin” repeat, anmotif. The DD is a roughly 60 amino acid globular bundle
of 6 conserved a helices found in the receptor tail and the oligomerization domain common to other signaling sys-
Cell
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precise pathways for activation of caspases, NF-kB, and
other cellular responses involve a variety of kinases such
as p38 and JNK, sphingomyelinase, Ca21, and other
specialized signaling proteins (Wajant et al., 1999; Idriss
and Naismith, 2000). Novel functions continue to emerge,
such as the recent finding that TRAF6 can function as
a nonproteolytic E3-like ubiquitin ligase implicated in
NF-kB activation (Deng et al., 2000). Intense investiga-
tion is ongoing to clarify these pathways.
Recent evidence has shown that TNFR chains preas-
semble into complexes on the cell surface prior to ligand
binding (Chan et al., 2000a; Siegel et al., 2000). The
formation of oligomers, possibly trimers, in the absence
of ligand requires the amino terminal end of the receptor
including the first CRD of Fas, TNFR1, and TNFR2. This
region, termed PLAD for “pre-ligand assembly domain”,
is necessary and sufficient for the self-assembly. Parallel
dimer structures resulting from the crystallization of the
unliganded TNFR 1 ectodomain show extensive con-
tacts in the PLAD region (Figure 1D) (Idriss and Naismith,
2000). The PLAD is distinct from the ligand binding do-
main and the unliganded complex that it promotes is in
a “closed” conformation that is distinct from the 3:3
ligand:receptor assembly. The PLAD interactions are
highly specific and usually only receptor homotrimers
are formed, however, “transplanting” the TNFR1 PLAD
onto TNFR2 allows it to enter TNFR1 complexes. Recep-
tor preassembly is essential for ligand binding and signal
transmission. The homotypic domain associations that
form the essence of receptor function represent key
molecular targets for pharmacological modulation either
outside the cell (PLAD, ligand-receptor) or inside the
cell (DD, TRAF and DED). The ligands can also preas-Figure 3. Sequence Alignments of the Amino-Terminal Cysteine-
semble into trimers on the cell surface, and several re-Rich Domains of TNFR-Related Proteins
ports suggest that membrane-anchored ligands canResidues are shaded (yellow for identities, red for conservative sub-
stitutions) where they occur in 30% of the grouped sequences. send “reverse” signals into the ligand-bearing cells
Sequences are assigned to 4 groups according to the organization when they contact their receptor, introducing the possi-
of the cysteine residues they contain. Alignments were generated bility of two-way signal transmission which warrants
using CLUSTALW. further exploration.
TNF/TNFR SFPs Are Cellular Organizerstems (Feinstein et al., 1995). Typically, these domains
are encoded by a single exon, a property that has been in Metazoans
TNF/TNFR SFPs are communicators between cells andconserved from Drosophila to mammals, suggesting a
genetic unit specialized in evolution. These domains can orchestrate permanent multicellular structures such
as lymphoid organs, hair follicles, and bone, as wellself-associate in a manner which can be blocked by
selective binding molecules (Humke et al., 2000; Siegel as impermanent, but long-lived, structures such as the
lactating mammary gland. Even more evanescent struc-et al., 2000). How the receptor complex activates down-
stream signaling pathways is not completely clear. The tures, inflammatory foci, are assembled and disassem-
Figure 4. Death Domain-Related Sequences in TNFR SF Proteins
The figure shows an alignment of death domain–related sequences found in the cytoplasmic regions of the indicated TNFR SF proteins. The
locations of a helices in the Fas death domain sequence are indicated at the top; these coincide closely with the location of a helices in the NGFR
structure. Residues are shaded (yellow for identities, red for conservative substitutions) where they are common to half or more of the sequences.
Alignments were generated using CLUSTALW.
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Figure 5. Interacting Proteins of the TNF/TNFR Superfamily
TNFR- and TNF-related proteins are shown at the left and right of the figure, respectively, with arrows connecting ligand–receptor pairs.
Cysteine-rich domains (CRDs) are shown as small ovals. The amino-terminal CRDs (CRD1a, 1b, 1c, 1d) are grouped on the basis of sequence
similarity (Figure 3) as indicated by the use of colors in the figure. Small vertical lines denote the locations of intron excision sites from the
RNAs that encode the proteins (this information was not available for RANK, DcR1, and DcR2). Red boxes mark the locations of death
domain–related sequences in the cytoplasmic regions of the TNFR-related proteins. Numbers to the immediate left of the TNFR cytoplasmic
regions denote known or inferred interactions with the indicated TRAFs. The locations of the human genes that encode the proteins are
provided at the extreme left and right of the figure; the mouse cluster on chromosome 17 is also noted. Potential interactions between TWEAK
and DR3, and between TRAIL and OPG, are controversial and are therefore represented by dashed arrows.
bled at limited times and locations in acute responses ancient somatic mechanisms to mediate recombination
and mutation of the combinatorial T cell receptor and Bto infectious stimuli. Broad regulatory patterns involving
specific TNF/TNFR SFPs emerge from these examples. cell receptor genes. Immune receptors thereby diversify
during differentiation so that a potentially huge reper-The genomic loci and receptor–ligand relationships of
the TNF/TNFR SF are depicted in Figure 5. toire of B and T lymphocytes (z109), each typically bear-
ing only a single receptor, is generated to ensure respon-
siveness to a large universe of antigens. Powerful asTNF/TNFR SFPs in the Immune System—
they are, however, lymphocytes cannot act individually.Coordinating Structure and Response
TNF/TNFR SFPs coordinate the social context of cellsThe major evolutionary advance represented in the ver-
that enables lymphocytes to maximally respond totebrate immune system is a system of “adaptive” or
pathogens. Cross-species comparisons suggest thatantigen-directed immunity in which TNF/TNFR SFPs
the largest expansion of new members of the TNF/TNFRplay central roles. This involved acquisition of the two
SF may have occurred during the refinement of therecombinase-activating genes, RAG1 and RAG2, z450
million years ago, as well as adapting perhaps more adaptive immune system (see below).
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Immune responses occur most effectively within sec- ent antibody subclasses. These processes depend on
antigen stimulation followed by engagement of CD40ondary lymphoid organs—aggregates of lymphocytes,
antigen-presenting cells, and other immune-responsive on the B cells by CD40L on T cells. CD40 or CD40L
deficiency impairs CD41 T cell priming, FDC differentia-cells positioned throughout the body with strategic vas-
cular connections to portals of infectious antigen entry. tion, GC formation, and class switching—so IgM-express-
ing cells cannot undergo isotype conversion to IgG ex-Remarkably, mice that are genetically deficient for LTb
(a1b2) or its receptor LTbR do not develop secondary pression, leading to hyper IgM syndrome (see below)
(Grewal and Flavell, 1998). Administration of neutralizinglymphoid organs, such as lymph nodes or Peyer’s
patches, and have defective spleen structure and hu- anti-CD40L in mature mice causes the abrupt disap-
pearance of existing GCs, revealing the need for tonicmoral immunity (Fu and Chaplin, 1999). Lymph node an-
lage, developing at embryonic day (E) 10.5 in the mouse, is CD40/CD40L interactions. Mice deficient for LTa, LTb,
TNF, and TNFR1 have severe defects in follicle and GCformed by invagination of mesenchymal connective tissue
constituents expressing LTbR. CD4-expressing hemato- formation (Fu and Chaplin, 1999). Recently, BlyS from
activated dendritic cells has been found to interact withpoietic cells seed the anlage and express lymphotoxin
(LTa1b2) which stimulates colonization by mature lym- the TACI and BCMA receptors on B cells and promote
their survival (Moore et al., 1999; Laabi and Strasser,phocytes. Deletion of RANKL or RANK results in the
absence of all peripheral and mesenteric lymph nodes 2000) (Table 1). Transgenic mice overexpressing BlyS
develop increased B cell numbers and autoimmunitybut Peyer’s patches remain intact and splenic architec-
ture is unaffected (Dougall et al., 1999; Kong et al., (Mackay et al., 1999). Conversely, TACI blockers inhibit
antibody production and GC formation in normal mice1999b; Kim et al., 2000a). Requirements for RANKL/
RANK and LTa1b2/LTbR do not complement one an- as well as abrogate autoantibody formation and fatal
immune complex–mediated nephritis in autoimmune-other. Whereas the latter are distributed on both hema-
topoietic and stromal cells, RANKL and RANK are ex- prone mice (Gross et al., 2000; Laabi and Strasser, 2000;
Yan et al., 2000a).pressed mainly on CD41 hematopoietic precursor cells.
This suggests that CD41 precursors emigrating into the T cell activation is also regulated by TNF/TNFR SFPs.
Except for a partial block in early thymocyte develop-lymph node anlagen use RANKL/RANK as an autocrine
survival/differentiative signal until LTa1b2 is produced ment in the absence of RANKL (Kong et al.,1999a), ef-
fects of TNF/TNFR SFPs in thymic development, CD4/and allows stromal interactions via LTbR to complete node
maturation (Kim et al., 2000a). Plasticity in lymphoid organ CD8 lineage commitment, or Th1/Th2 differentiation are
minimal. However, the initiation of an immune responseboundaries is shown by ectopic expression of LTa3 or
LTa1b2—or of B cell chemokines induced by LTa3/ by sentinel dendritic cells originating in epithelial barri-
ers stimulating naive T cells in draining lymph nodesLTa1b2 on B cells—which stimulates vascular adhesion
molecules typical of specialized lymph node endothelia involves TNF/TNFR SFPs. Both TNFR and Fas can ex-
perimentally costimulate T cell activation, but this effectand generates ectopic lymphoid tissue (Kratz et al.,
1996; Cuff et al., 1999; Luther et al., 2000). Conversely, requires further examination in a physiological setting
(Siegel et al., 2000). Additional TNF/TNFR SFPs, includ-mice deficient in LTbR or its ligands develop perivascu-
lar T cell and B cell infiltrates in multiple tissues (Banks ing OX40, CD27, and 4-1BB, regulate the expansion
and survival of CD41 and CD81 T cells responding toet al., 1995; Alimzhanov et al., 1997). Hence, an ordered,
sequential process of TNF/TNFR SFPs promotes gener- dendritic cells that express their respective ligands;
LIGHT may have a similar role (Tamada et al., 2000).ative interactions between hematopoietic and mesen-
chymal cells, and establishes spatial constraints essen- Thus far, targeted deletions of these molecules have
less drastic consequences on the immune responsetial for lymphoid organ definition (Nishikawa et al., 2000).
than does CD40/CD40L (Table 1). Most TNF/TNFR SFPs
are expressed in activated T cells suggesting that criticalParticipation in Acute Immune Responses
immune functions for additional family members awaitSuperimposed on the architecture of lymphoid organs
discovery.is the coalescence of follicles and germinal center (GC)
reactions facilitated by TNF/TNFR SFPs during active
immune responses. These are cellular aggregates com- TNF/TNFR SFPs as Mediators of Cell Death
The capacity to induce cell death is one of the uniqueprising mostly B cells but also T cells and follicular den-
dritic cells (FDCs) (Cyster et al., 2000). FDCs are special- properties with great adaptive value that TNF/TNFR
SFPs have evolved. Among the 8 homologous deathized mesenchymal cells that collect antigens in draining
lymph nodes, interact with clonally expanding B cells, receptors (DRs) in the TNFR superfamily (Figure 4), at
least 6 can stimulate apoptosis through activation of aand form networks in the follicle under the influence of
TNF, LTa, LTb, TNFR1, and LTbR (Fu and Chaplin, 1999). family of cysteine proteases called caspases (Raff, 1998;
Screaton and Xu, 2000). Other TNF/TNFR SFPs that lackIn the spleen, 3% of the total volume of the organ can
be occupied by B cell–rich GCs during the peak of an death domains can potently modulate the response to
DRs or directly influence cell survival. For example,antigen response, yet these GCs will largely disappear
by 4 weeks. The residue is a collection of memory lym- TNFR2 markedly enhances TNFR1-induced T cell death
and CD40 can augment Fas-induced B cell death (Gar-phocytes that respond more efficiently to previously en-
countered antigens. In GCs, B cells are stimulated and rone et al., 1995; Chan et al., 2000b). One major function
of DR-induced death is cell-mediated cytotoxicity in re-somatically hypermutate their antigen receptor genes;
those with better antigen avidity are selected and can sponse to infectious agents. Fas-mediated cytotoxicity
is the major calcium-independent killing mechanism ofundergo heavy chain class switching to produce differ-
Review
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CD81 cytotoxic T cells (Nagata and Golstein, 1995). An- rapid recruitment of many inflammatory cell types to the
site of an infection. When the infectious danger has beenother crucial function of DR-mediated death is immune
contained, it is essential that inflammation subsides andhomeostasis to balance recurrent lymphocyte expan-
normal tissue homeostasis is restored. Rapid responsesion in response to antigen within the limited space of
and rapid subsidence are crucial to prevent damage tolymphoid organs. Activated cells must be destroyed,
the host by microbial replication or persistent inflamma-sometimes in enormous numbers. High or repeated anti-
tion, respectively.gen stimulation of activated T cells induces these death
Of the many TNF/TNFR SFPs that affect inflammation,molecules and causes apoptosis in a fraction of the ex-
TNF has a prominent role. TNF secretion can be inducedpanding cell population. This negative feedback mecha-
by conserved structural elements common to microbialnism, termed propriocidal regulation, prevents the toxic
pathogens, including cell wall moieties such as pepti-effects of massive lymphocyte expansion (reviewed in
doglycan, lipopolysaccharide (LPS), and bacterial DNALenardo et al., 1999). Genetic impairment of Fas-
CpG motifs, that are bound by Toll-like receptors (TLRs)induced apoptosis in humans (ALPS) or mice (lpr/gld)
(Aderem and Ulevitch, 2000). TLRs, conserved in proteincauses a dramatic loss of lymphocyte homeostasis and
sequence from Drosophila to humans, decorate epithe-autoimmunity (Rieux-Laucat et al., 1995; Lenardo et al.,
lial cells, tissue macrophages, and dendritic cells, of1999). Self-tolerance mechanisms also involve TNF and
which the latter two are the sentinel phagocytic anddysregulation of TNF has been associated with human
antigen processing cells of the immune system, respec-systemic lupus erythematosus and other autoimmune
tively. TLRs transcriptionally induce proinflammatoryconditions (Jacob et al., 1991).
cytokines, including TNF, through the convergence ofMuch is known about how TNF/TNFR SFPs program
NF-kB and NF-AT activating pathways, and enhancecell death, but new concepts are still emerging. Cell death
translational efficiency by a mechanism targeting con-has been conceptually divided into two principal forms:
sensus 39-untranslated AU-rich elements (ARE) in mRNAapoptosis (programmed cell death) and necrosis (trau-
(Dumitru et al., 2000). IL-1R, a receptor that shares cyto-matic cell death) (Raff, 1998). There are key morphologi-
plasmic homology with TLRs, and integrin interactionscal differences—apoptosis causes shrinkage, compac-
with extracellular matrix proteins activate similar path-tion, and breakdown of the cell into easily phagocytosed
ways, thus amplifying the response (Shornick et al.,bits whereas necrosis involves swelling or bursting of
1996; de Fougerolles et al., 2000). The result is a highlythe cell with organelle degeneration and loss of plasma
complex biologic cascade—involving chemokines, cy-membrane integrity. Molecularly, apoptosis involves
tokines, and the induction of endothelial adhesins—thatevolutionarily conserved pathways of caspase activa-
recruits and activates granulocytes, monocyte/macro-tion, but necrosis is less well defined (Raff, 1998). Death
phages, and lymphocytes at the damaged or infectedreceptors within the TNFR SF are among the best-under-
tissue sites. Local injection of TNF recapitulates thesestood inducers of caspase activation and apoptosis.
events, and TNF- and TNFR-deficient mice show attenu-This appeared ironic given the moniker “tumor necrosis
ated contact hypersensitivity to irritants and susceptibil-factor.” However, apoptosis is unable to explain all the
ity to diverse microbial pathogens (Pfeffer et al., 1993;death capabilities of these receptors. Death receptor
Rothe et al., 1993; Erickson et al., 1994; Pasparakis etkilling in cells without caspase activation and other attri-
al., 1996).butes of apoptosis have now been carefully documented
Studies of how TNF mRNA stability is regulated by(Kawahara et al., 1998; Vercammen et al., 1998; Villunger
the presence of an ARE sequence in the 39-untranslatedet al., 2000). One important example is vaccinia virus.
region may provide insights into the role of TNF/TNFRAlthough the virus encodes a potent caspase inhibitor,
SFPs and lymphokines in disease. The ARE is commoninfected cells are nonetheless killed by TNF in a manner
to many cytokine mRNAs and is bound by tristetraprolinthat does not resemble apoptosis molecularly or mor-
(TTP), a zinc finger–containing protein that accelerates
phologically (Li and Beg, 2000). For lack of a better term,
the turnover of ARE-containing mRNAs (Carballo et al.,
these examples have been called necrosis and may be
1998). TTP is induced by TNF as a negative feedback
associated with inflammation. Inflammation is not typi- loop that limits TNF activity. Mice lacking TTP develop
cally found with apoptosis, but may be extremely impor- spontaneous, chronic, TNF-induced inflammation, with
tant for activating the immune system when TNF- cachexia, arthritis, and high-titers of anti-DNA antibod-
induced necrosis is part of an anti-pathogen response. ies dependent upon TNFR1 (Taylor et al., 1996). Mice
Conversely, purely apoptotic pathways may be involved containing TNF genes with a deleted ARE sequence
in tissue remodeling during development, where inflam- are similar, although inflammatory bowel disease also
mation could be detrimental. Experiments dissecting occurs (Kontoyiannis et al., 1999). Mice deficient in
TNFR-induced apoptotic and necrotic pathways may TRAF2 (Nguyen et al., 1999) or the TRAF2-interacting
uncover fundamental pathways used by these ligand/ zinc finger protein, A20 (Lee et al., 2000), also develop
receptors in development and host defense. states of TNF excess, suggesting that TRAF2-depen-
dent pathways are involved in negative feedback, per-
Organizing Reversible Microenvironments haps through activation of p38 and JNK (Kontoyiannis
in Response to Acute Environmental et al., 1999).
Perturbations—Acute Inflammation Spatial and temporal constraints on inflammation by
as a Paradigm TNFR/TNF SFPs are imposed by feedback inhibition;
The role of TNF/TNFR SFPs in acute inflammation illus- regulated expression of receptors; soluble processing of
trates how they achieve dramatic cellular change and membrane-tethered ligands and receptors into soluble
forms; and the induction of nonsignaling decoy recep-dynamic tissue remodeling. Host defense relies on the
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tors. Perhaps the most innovative form of regulation for CD40L in experimental models of atherosclerosis both
both ligands and receptors of the TNF/TNFR SFP is the interrupt progression of lesions and change their com-
proteolytic release of soluble bioactive oligomers from position to a more stable, collagen-anchored, character
membrane-bound precursors. For TNF, this is accom- (Lutgens et al., 1999). Patients with unstable angina, a
plished by TACE, a cis-acting membrane protease of the condition associated with risk of plaque rupture and
metalloprotease/disintegrin/cysteine-rich family, whose heart attacks, demonstrate high levels of serum CD40L,
regulation is currently obscure (Blobel, 1997). Release raising prospects of targeting the TNF/TNFR SFPs in
of TNF systemically may promote viral infection and human atherosclerosis (Aukrust et al., 1999).
cause other pathogenic effects in viral diseases such
as AIDS (Fauci et al., 1991). Cleavage from the mem- Regulators of Bone and Mammary
brane likely expands the range over which ligands can Gland Homeostasis
act, but may also be responsible for more specific ef- Besides lacking secondary lymph nodes, mice deficient
fects. For example, stimulation of TNFR2 for certain in RANKL or its receptor, RANK, have severe os-
functions may occur primarily through membrane- teopetrosis (increased bone density) (Kong et al.,
bound, but not soluble, TNF (Idriss and Naismith, 2000). 1999a). Normal skeletal homeostasis precisely balances
Also, lymph node development is predominantly trig- bone-forming osteoblasts and bone-resorbing osteo-
gered by membrane-bound, but not soluble, LT (Fu and clasts, derived from distinct mesenchymal and hemato-
Chaplin, 1999). TACE and/or related proteases cleave poietic lineages, respectively. Bone-resorbing agents,
TNFRs, thus generating soluble receptors capable of including vitamin D3, parathyroid hormone, and proin-
inhibiting TNF. Early lethality in TACE-deficient mice flammatory cytokines, such as IL-1 and TNF, induce
suggests that proteolytic release is a developmentally RANKL in stromal cells/osteoblasts. RANKL mediates
crucial process that has been subserved by the TNF/ the differentiation and activation of osteoclasts from a
TNFR SFPs (Peschon et al., 1998). Some TNFR mem- monocyte precursor. RANKL or RANK deficiency ab-
bers, for example, DcR3 and OPG, have evolved a solu- lates osteoclasts, revealing an essential role in normal
ble function by loss of a transmembrane domain, osteoclast survival/differentiation (Kong et al., 1999b;
whereas others, for example DcR1 and DcR2, can be Kim et al., 2000b; Li et al., 2000). TRAF6-deficient mice
membrane-tethered but lack a functional death domain. also lack osteoclasts, indicating that this adaptor trans-
Although regulation through cleavage of TNF/TNFR duces RANK signals (Lomaga et al., 1999). These mutant
SFPs remains a plausible but unproven regulatory mice have dense bones and fail to thrive due to loss of
mechanism, constitutional inflammation and fever in tooth eruption, a process that requires bone resorption
certain cases of TNF receptor–associated periodic syn- to allow the passage of teeth through the jawbone. Hy-
drome (TRAPS, see below) may be due to defective percalcemia induced by bone-resorbing agents such as
proteolytic shedding of TNFR1 (Galon et al., 2000). Ge- vitamin D3, parathyroid hormone, and IL-1 is defectivenetically engineered soluble forms of TNF/TNFR SFPs in RANK/RANKL-deficient mice (Li et al., 2000). TNF both
have been widely used for both research and clinical synergizes with RANKL to promote osteoclastogenesis
applications. Typically, fusions with immunoglobulin or
(Lam et al., 2000), and acts independently to induce
leucine zipper oligomerization domains are used to
osteoclast development and bone resorption restricted
achieve high-level activity of the soluble ligand or recep-
to localized sites of injection in RANK/RANKL-deficient
tor (Haak-Frendscho et al., 1994; Walczak et al., 1999).
mice (Li et al., 2000). In infectious diseases, RANKL andInflammatory conditions such as arthritis, inflammatory
TNF expressed by activated CD41 T cells can causebowel disease, and TRAPS have been successfully
bone erosion (Kong et al., 1999b; Teng et al., 2000).treated with soluble TNFR2-Ig fusion protein constructs
Negative regulation of bone resorption during inflamma-(Galon et al., 2000).
tion may be provided by IFN-g, which activates TRAF6Left unregulated, TNF can cause chronic inflamma-
degradation, thereby blocking RANK signaling (Takaya-tion, generalized wasting and, at high levels, septic
nagi et al., 2000). Thus, in both mice and humans, TNF/shock (Idriss and Naismith, 2000); lymphotoxin can in-
TNFR SFPs have central roles in regulating osteoclastduce acute virus-induced shock (Puglielli et al., 1999).
differentiation and activation—and, hence, calcium stor-Other TNF/TNFR SFPs may be similarly involved in dis-
age and mobilization.ease pathogenesis. CD40 is induced on vascular endo-
Osteoporosis—bone thinning—is a major medical prob-thelial cells in response to TNF (Phipps, 2000). Ligation
lem for postmenopausal women and may be regulated byof endothelial CD40 by CD40L, either expressed on acti-
the production of OPG, a soluble RANKL decoy receptor,vated monocytes or T cells, or disgorged from platelet
made by stromal cells and osteoblasts. Estrogen inducesgranules after activation, produces various inflamma-
OPG, potentially explaining postmenopausal osteopo-tory cytokines, chemokines such as MCP-1, procoagu-
rosis and the protective effects of estrogens on bone.lant activity, adhesion molecules, matrix-degrading met-
Estrogen deficiency, at least in experimental animals, isalloproteinases, and inflammatory lipid mediators.
also associated with enhanced RANKL and TNF produc-Atherosclerotic plaques formed in this milieu are popu-
tion by T cells (Cenci et al., 2000).lated by lipid-laden macrophages derived from MCP-1-
In addition to their critical function in bone homeosta-recruited blood-borne monocytes. Normally, the plaque
sis, RANKL/RANK signals also govern the terminal dif-microenvironment will dissolve upon loss of chronic
ferentiation of mammary gland alveolar buds to createCD40-CD40L-mediated signals, exemplifying the inher-
lobulo-alveolar structures competent for lactation (Fataent reversibility of TNF/TNFR SFP-induced neo-tissues.
et al., 2000). Pregnant RANKL-deficient mice fail to formHowever, TNF or other inflammatory stimuli may pro-
mote plaque extension. Interventions that disrupt CD40- lactating breast tissues or produce the major milk pro-
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tein, b-casein. Without RANK, mammary epithelial pre- tifs, and supports the development of sensory neurons
by interactions with high-affinity nerve growth factorcursors undergo accelerated apoptosis because of a
failure to activate the antiapoptotic Protein Kinase B receptors (Bibel and Barde, 2000). Alone, NFGR can
mediate apoptosis. NGFR can associate physically with(PKB/AKT). FasL/Fas may also play a role in early involu-
tion of the mammary gland postpartum (Song et al., high-affinity receptors of the Trk family, however, and
promote differentiation and survival, presumably re-2000). RANKL/RANK involvement in mammary gland de-
velopment during pregnancy presumably occurred with flecting differential displacement of downstream adap-
tors in the presence or absence of the associating recep-the appearance of mammals 200 million years ago and
may have coordinated the transfer of minerals mobilized tors (Salehi et al., 2000). NGFR is critical in mediating
the structural plasticity required for development of afrom the mother’s bone through the milk to the growing
skeleton of the newborn. Both bone metabolism and sensory cutaneous network responsive to environmental
stimuli; NGFR-deficient mice manifest severe cutaneousmammary gland maturation illustrate the powerful capa-
bilities of TNF/TNFR SFPs—homeostatic regulation, sensorineural defects (Lee et al., 1992).
spatial organization of tissues and inherently reversible
effects. Genomic and Sequence Relationships of the TNF/
TNFR SFPs
Hair Follicle and Sweat Gland Development In Figure 5, we show the proteins of the TNF/TNFR
Hair follicle formation in the mouse begins around SF and their known ligand-receptor interactions. The
E16.5–18.5 with intense NGFR expression in the mesen- proteins have been grouped according to sequence
chymal condensation that forms the dermal papillae comparisons and based on the locations of their genes
(Botchkareva et al., 1999). The epidermal–dermal sand- in the human genome. The groupings represented in the
wich in skin represents a complex interplay between figure suggest relationships that are interesting from an
mesenchymal dermal fibroblasts and epidermal kera- evolutionary standpoint. As the genomes of different
tinocytes. Cell renewal in hairy skin, especially re-epithe- species are sequenced, it seems likely that some of
lialization after injury, may involve stem cells that arise these relationships will be solidified such that it may
from a specialized structure, the follicular bulge, in the eventually be possible to trace the evolution of the SF.
hair follicle (Taylor et al., 2000). The sebaceous glands Although speculation along these lines is largely beyond
develop as an appendage of the hair follicle adjacent the scope of this review, a few observations deserve
to the bulge. During hair follicle development, NGFR brief comment.
expression is attenuated as the ectoderm placodes in- Death domains are present in two of the ten proteins
vaginate at dermal papillae to localize developing folli- located in the clusters on human chromosomes 1 and
cles. Thereafter, NGFR remains localized to the sensory 12. These clusters include genes that regulate the devel-
neurons that innervate the follicular bulge and to cells of opment and organization of lymphoid tissue (the genes
the outer root sheath. NGFR-deficient mice demonstrate for LT and TNF receptors) and other immunoregulatory
developmentally accelerated hair follicle development, genes, including 4-1BB, CD27 and OX40 (Table 1). It
suggesting a negative regulatory effect important in seems improbable that the single exon encoding the DD
temporally coordinating mesenchymal-ectodermal events was introduced separately into similar locations within
(Botchkareva et al., 1999). single TNFR-like genes in each cluster. Instead, it is
Additional members of the TNF/TNFR SFP—the re- perhaps more likely that the ten genes were derived from
ceptors EDAR, XEDAR, and Troy, as well as the ligand a common ancestor that encoded a TNFR-like receptor
EDA—help form the hair follicle. EDAR and Troy appear linked to a cytoplasmic DD. If so, the recent expansion
in developing and invaginating placodes that originate of the TNFR SF apparently favored the replication of
above the NGFR-rich dermal condensations. By con- genes encoding receptors that could signal not through
trast, EDA is expressed ubiquitously in developing skin direct linkage to a DD, but instead by interactions with
in cleaved, diffusible form. Thus, spatiotemporal regula- other adaptors (most notably TRAFs). TRAFs require
tion is maintained by receptor expression. Mice deficient only a short stretch of amino acids for binding, a charac-
in either EDA (tabby) or EDAR (downless) have no pri- teristic that could allow for rapid functional diversifica-
mary hair follicles or sweat glands and have malformed tion during gene duplication and divergence (McWhirter
teeth (Headon and Overbeek, 1999). Human mutations et al., 1999; Park et al., 1999; Ye et al., 1999). The geno-
in EDA and EDAR cause similar effects (Monreal et al., mic organization thus hints at a key role for DD-con-
1999). The Troy locus maps near the mouse Wv (wavy) taining receptors in the evolution of the modern immune
mutation, an autosomal dominant hair phenotype that system, with the later addition of derivative receptors
is lethal when homozygous, hinting that Troy may be for more specialized functions.
responsible for this phenotype (Kojima et al., 2000). Fi- Troy, EDAR, and XEDAR share protein sequence (Fig-
nally, crinkled is a mouse X-linked mutation that pheno- ure 3) and functional similarities, although here again,
copies EDA/EDAR deficiency, and might represent an only EDAR has a DD-related sequence in its cytoplasmic
XEDAR mutation. region. EDAR and XEDAR bind to the products of the
EDA-A1 and EDA-A2 transcripts, which are alternatively
spliced RNAs derived from the X-linked EDA gene (YanAn Unusual Regulator of Neural Development
NGFR is the most divergent member of the TNFR family, et al., 2000b). Striking patches of identity in the DDs of
EDAR and NGFR (Figure 4) raise the possibility thatwith no known TNF ligand and a propensity to dimerize
rather than trimerize. NGFR shares cytoplasmic death EDAR could have diverged from the NGFR gene and
then subsequently given rise to Troy and XEDAR. Asdomain-like sequences (Figure 4) and TRAF binding mo-
Cell
498
mentioned above, an early founding role for the NGFR to resorption are common clinical manifestations. To-
gether, these diseases underscore the diverse functionsin the evolution of the TNFR SF might also be suggested
by the fact that it does not bind a TNF-related ligand, mediated by TNF/TNFR SFP and illustrate the types of
genetic mechanisms that could underlie diseases in-and by the fact that (like the DR6 and OPG genes) its
gene lacks the typical distribution of introns in its CRD- volving other TNF/TNFR SFPs.
encoding region (Figure 5). Interestingly, TACI and
BCMA share loose protein sequence similarity with Troy, Conclusions: Looking to the Past
EDAR, and XEDAR (Figure 3) and the genes encoding We have attempted to summarize and conceptualize
their ligands (APRIL and BLYS) have introns placed in the structure, function, and genomic organization of the
similar locations to those in EDA. From such observa- TNF/TNFR SFP. Functional studies based on gene
tions, it is possible to suggest that the genes for TACI knockout mice and natural human mutations support a
and BCMA may have derived from the NGFR gene role for these proteins in modulating dynamic, multicel-
through duplication of an intermediate EDAR-related lular interactions important to diverse developmental
gene. As with the genes on chromosomes 1 and 12, if and homeostatic needs. The pairing of modular cyste-
this hypothesis is accurate, the expansion of the TNFR ine-rich ectodomains with existing internal death do-
SF has involved the generation of additional specialized mains and the evolution of TRAF adaptor binding motifs
receptors from founder DD-containing receptors. provided a powerful signaling mechanism used repeat-
edly in different contexts for coupling diverse environ-
mental stimuli to downstream differentiation pathways.Mechanisms of Genetic Diseases of TNFRs
There are four well-defined genetic diseases that affect These downstream adaptor/signaling modules were
previously tested in evolution, with members repre-ligand:receptor interactions in the TNFR SF: X-linked
hyper IgM syndrome (HIGM-1, involving CD40:CD40L), sented in the genomes of flies and worms that had
already been adapted to body plan development andthe autoimmune lymphoproliferative syndrome (ALPS,
involving Fas:FasL), TNF receptor-associated periodic innate immunity. Although no clear TNFR-like homologs
have been discovered, FADD-, RIP-, and TRAF-like mol-syndrome (TRAPS, involving TNFR1:TNF), and anhi-
drotic ectodermal dysplasia (EDA, involving EDAR/ ecules have been identified in Drosophila (Khush and
Lemaitre, 2000), and TRAF-like molecules in C. elegansXEDAR:EDA). A fifth disease, familial expansile osteo-
lysis (FEO, involving RANK/RANKL), has been linked (Wajant et al., 1999). Caspases are present in both or-
ganisms (Ruvkun and Hobert, 1998; Rubin et al., 2000).with signal peptide mutations in RANK and leads to lytic
bone lesions (Hughes et al., 2000). The most common Recently, the gene for a death receptor-like molecule
was identified in zebrafish (Long et al., 2000). Furthergenetic mechanism for most cases of ALPS is autosomal
dominance (gain of function), involving heterozygous studies in birds and fish will be required to trace the
process by which TNF/TNFR SFP became peculiarlydominant-interfering alleles. These alleles encode de-
fective Fas proteins that complex with normal Fas pro- adapted to mammals. NGFR, like other neurotrophins,
is found only in vertebrates, with the earliest genes iden-teins, thereby impairing apoptosis signaling and causing
marked lymphoid expansion and autoimmunity (Len- tified in jawless fish, which arose about 460 million years
ago during the period of acquisition of the RAG genesardo et al., 1999; Siegel et al., 2000). Afflicted individuals
develop pathogenic auto-antibodies—frequently against critical for the subsequent development of adaptive im-
munity (Hallbook, 1999). A TNF homolog in bony (teleost)hematopoietic cells—that cause hemolytic anemia,
thrombocytopenia, or neutropenia (Rieux-Laucat et al., fish suggests divergence from mammalian TNF long be-
fore the appearance of LT—found thus far only in mam-1995). In TRAPS, heterozygous dominant alleles of
TNFR1 with amino acid changes in the extracellular do- mals and marsupials—but more extensive comparative
analyses will be necessary (Hirono et al., 2000). Intrigu-main apparently cause enhancement of the proinflam-
matory effects of TNF. This may result, at least in part, ingly, the 3-fold jelly-roll structure of TNF is remarkably
similar to the capsid proteins of small RNA virusesfrom a decrease in TNFR1 shedding (Galon et al., 2000).
By contrast, HIGM-1 is typically caused by recessive (Fesik, 2000). Several avian virus receptors are TNFRs,
and human HveA supports herpes virus attachmentmutations (loss of function) in the X-linked gene encod-
ing CD40L. Hence, this severe immunodeficiency, char- (Mauri et al., 1998; Adkins et al., 2000). The similar intra-
cellular signaling domains of some TNFR and TLRs,acterized by defective CD40-mediated antibody class
switching in B cells, is found mostly in males and rarely which function as germline-encoded receptors for
pathogen-encoded structures, raise the possibility thatin females with skewed X-chromosome inactivation (No-
tarangelo and Hayward, 2000). EDA can result from ei- TNF ligands represent descendents from the horizontal
capture of a gene encoded by an ancient viral pathogen.ther dominant or recessive mutations, but in both cases,
the genetic aberrations cause defective ligand-receptor If, as argued above, TNF/TNFR SFP gene diversifica-
tion radiated from early NGFR-like or TNFR1-like precur-interactions necessary for the normal differentiation of
ectodermal placodes into hair, sweat glands, and teeth sors, evolution has apparently found these molecules
to be valuable instruments in generating multicellular(Yan et al., 2000b). FEO, as well as some cases of familial
Paget disease of bone (PDB), has been linked with signal organs and transient microenvironments, or neo-tis-
sues, that respond to external environmental conditions.peptide mutations in RANK that lead to activating phe-
notypes (Hughes et al., 2000). Dominant inheritance re- These multicellular responses have evolved to be rapid,
reversible and ultimately, to achieve equipoise in cellularsults in the appearance in young adulthood of expansile
osteolytic lesions in the long bones (FEO) or skull and numbers and activation. To achieve this, signaling via
TNF/TNFR SFPs is spatially constrained during the orga-pelvis (PDB). Early deafness and loss of adult teeth due
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independent receptor assembly and signaling. Science 288, 2351–nization of neo-tissues and then dispersed upon re-
2354.moval of tonic signals. As we hope to have illustrated,
Chan, F.K.-M., Siegel, R.M., and Lenardo, M.J. (2000b). Signalingthese functions have been most elaborately explored in
by the TNF receptor superfamily and T cell homeostasis. Immunitythe immune system, but also govern similar adaptive
13, 419–422.responses in bone, skin, mammary gland, and perhaps
Cuff, C.A., Sacca, R., and Ruddle, N.H. (1999). Differential inductionother organ systems whose molecular organization
of adhesion molecule and chemokine expression by LTalpha3 andawaits discovery. LTalphabeta in inflammation elucidates potential mechanisms of
mesenteric and peripheral lymph node development. J. Immunol.
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